MarketBeat on MSN
3 biotech stocks that look like sure-fire winners in 2026
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...
24/7 Wall St. on MSN
3 biotech stocks that could double in 2026
The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
In this article, we will take a look at 9 Oversold Biotech Stocks to Invest In. Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value ...
In this piece, we discuss the 10 Best Small-Cap Biotech Stocks to Buy According to Analysts. Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention. This ...
The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.
It’s been a big year for European biotech stocks: Abivax SA soared about 1,300% after successful trial results for a bowel disease drug, Argenx SE was added to the elite Euro Stoxx 50 Index and ...
Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded away Eli Lilly's weight-loss drug Zepbound is on track to be the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results